Literature DB >> 19052183

Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease.

Li Zhang1, Si Ming Man, Andrew S Day, Steven T Leach, Daniel A Lemberg, Shoma Dutt, Michael Stormon, Anthony Otley, Edward V O'Loughlin, Annabel Magoffin, Patrick H Y Ng, Hazel Mitchell.   

Abstract

The presence of Campylobacter species other than Campylobacter jejuni and antibodies to Campylobacter concisus in children were investigated. A significantly greater presence of C. concisus and higher levels of antibodies to C. concisus were detected in children with Crohn's disease (CD) than in controls. Campylobacter species other than C. jejuni were isolated from intestinal biopsy specimens of children with CD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19052183      PMCID: PMC2643684          DOI: 10.1128/JCM.01949-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

Review 1.  Bacteria as the cause of ulcerative colitis.

Authors:  M Campieri; P Gionchetti
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

Review 2.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

3.  Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum.

Authors:  P Rutgeerts; K Goboes; M Peeters; M Hiele; F Penninckx; R Aerts; R Kerremans; G Vantrappen
Journal:  Lancet       Date:  1991-09-28       Impact factor: 79.321

4.  Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection.

Authors:  P Rutgeerts; M Hiele; K Geboes; M Peeters; F Penninckx; R Aerts; R Kerremans
Journal:  Gastroenterology       Date:  1995-06       Impact factor: 22.682

5.  Specific detection of Campylobacter concisus by PCR amplification of 23S rDNA areas.

Authors:  K Bastyns; S Chapelle; P Vandamme; H Goossens; R De Wachter
Journal:  Mol Cell Probes       Date:  1995-08       Impact factor: 2.365

6.  A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.

Authors:  B Ursing; T Alm; F Bárány; I Bergelin; K Ganrot-Norlin; J Hoevels; B Huitfeldt; G Järnerot; U Krause; A Krook; B Lindström; O Nordle; A Rosén
Journal:  Gastroenterology       Date:  1982-09       Impact factor: 22.682

7.  The mucosa-associated microflora of the rat intestine: a study of normal distribution and magnesium sulphate induced diarrhoea.

Authors:  M Phillips; A Lee; W D Leach
Journal:  Aust J Exp Biol Med Sci       Date:  1978-12

8.  Evaluation of antibiotic therapies for eradication of Helicobacter hepaticus.

Authors:  C J Foltz; J G Fox; L Yan; B Shames
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

9.  Investigation of the immunomodulatory effects of Lactobacillus casei and Bifidobacterium lactis on Helicobacter pylori infection.

Authors:  Li Zhang; Ping Su; Anders Henriksson; Jani O'Rourke; Hazel Mitchell
Journal:  Helicobacter       Date:  2008-06       Impact factor: 5.753

10.  Characterization of a haemolytic phospholipase A(2) activity in clinical isolates of Campylobacter concisus.

Authors:  Taghrid S Istivan; Peter J Coloe; Benjamin N Fry; Peter Ward; Stuart C Smith
Journal:  J Med Microbiol       Date:  2004-06       Impact factor: 2.472

View more
  65 in total

Review 1.  IBD-what role do Proteobacteria play?

Authors:  Indrani Mukhopadhya; Richard Hansen; Emad M El-Omar; Georgina L Hold
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

2.  Campylobacter jejuni disrupts protective Toll-like receptor 9 signaling in colonic epithelial cells and increases the severity of dextran sulfate sodium-induced colitis in mice.

Authors:  Jennifer R O'Hara; Troy D Feener; Carrie D Fischer; Andre G Buret
Journal:  Infect Immun       Date:  2012-02-06       Impact factor: 3.441

3.  Campylobacter concisus: a new character in the Crohn's disease story?

Authors:  Mario Guslandi; Li Zhang; Si Ming Man; Andrew S Day; Steven T Leach; Daniel A Lemberg; Shoma Dutt; Michael Stormon; Anthony Otley; Edward V O'Loughlin; Annabel Magoffin; Patrick H Y Ng; Hazel Mitchell
Journal:  J Clin Microbiol       Date:  2009-05       Impact factor: 5.948

Review 4.  Clinical relevance of infections with zoonotic and human oral species of Campylobacter.

Authors:  Soomin Lee; Jeeyeon Lee; Jimyeong Ha; Yukyung Choi; Sejeong Kim; Heeyoung Lee; Yohan Yoon; Kyoung-Hee Choi
Journal:  J Microbiol       Date:  2016-06-28       Impact factor: 3.422

5.  Clinical relevance of Campylobacter concisus isolated from pediatric patients.

Authors:  Albert J Lastovica
Journal:  J Clin Microbiol       Date:  2009-07       Impact factor: 5.948

6.  Rifaximin and Crohn's disease: a new solution to an old problem?

Authors:  A S Day; R B Gearry
Journal:  Dig Dis Sci       Date:  2010-04       Impact factor: 3.199

7.  The internal transcribed spacer region, a new tool for use in species differentiation and delineation of systematic relationships within the Campylobacter genus.

Authors:  Si Ming Man; Nadeem O Kaakoush; Sophie Octavia; Hazel Mitchell
Journal:  Appl Environ Microbiol       Date:  2010-03-26       Impact factor: 4.792

Review 8.  Global Epidemiology of Campylobacter Infection.

Authors:  Nadeem O Kaakoush; Natalia Castaño-Rodríguez; Hazel M Mitchell; Si Ming Man
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

9.  Transcriptomic and proteomic analyses reveal key innate immune signatures in the host response to the gastrointestinal pathogen Campylobacter concisus.

Authors:  Nadeem O Kaakoush; Nandan P Deshpande; Si Ming Man; Jose A Burgos-Portugal; Faisal A Khattak; Mark J Raftery; Marc R Wilkins; Hazel M Mitchell
Journal:  Infect Immun       Date:  2014-12-08       Impact factor: 3.441

Review 10.  Campylobacter concisus and inflammatory bowel disease.

Authors:  Li Zhang; Hoyul Lee; Michael C Grimm; Stephen M Riordan; Andrew S Day; Daniel A Lemberg
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.